BioSpace News Archive

Deals

Numab AG Reacquires Advanced Compound From Sucampo Pharmaceuticals, Inc.

October 29, 2013
·
1 min read
Drug Development

Sophiris Bio Inc. Announces First Patients Dosed in the “PLUS-1" Phase 3 Trial of PRX302 for Benign Prostatic Hyperplasia

October 29, 2013
·
1 min read
Business

bioTheranostics Signs Collaboration Agreement With Top U.S. Hospital and Reference Laboratory to Offer CancerTYPE ID® Molecular Test for Metastatic Cancer

October 29, 2013
·
1 min read
BioMidwest

ARCA biopharma Announces IND Submission to FDA for Gencaro for the Treatment of Atrial Fibrillation

October 29, 2013
·
1 min read
Drug Development

Alvine Pharmaceuticals, Inc. Doses First Patient in Phase 2b Trial for ALV003 in Celiac Disease

October 29, 2013
·
1 min read
Business

CEL-SCI and ErgoMed Sign Co-Development and Profit Sharing Agreement for Multikine in HIV/HPV Co-Infected Men and Women With Peri-Anal Warts

October 29, 2013
·
1 min read
Drug Development

Positive Results Presented from Proof-of-Concept Phase II Clinical Trial of Incyte Corporation’s Oral JAK1 Inhibitor in Patients With Active Rheumatoid Arthritis

October 29, 2013
·
1 min read
Drug Development

Alnylam Pharmaceuticals Files Clinical Trial Application to Initiate a Phase I Study for ALN-AT3, a Subcutaneously Administered RNAi Therapeutic Targeting Antithrombin (AT) for the Treatment of Hemophilia A and B

October 29, 2013
·
1 min read
BioForest

Bend Research Improves Speed-to-Clinic Capability for Oral and Inhalation Formulation Development

October 29, 2013
·
1 min read
CartiHeal Announces $5 Million Raised in Continued Funding Round

October 29, 2013
·
1 min read